A plan for pharma vouchers in Europe; new pressure on FDA and NIH over clinical trial reporting

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: Will the European Union give vouchers to pharma to develop badly needed antibiotics? By Ed Silverman Melissa Brower/Centers for Disease Control and Prevention via AP A battle is brewing in the European Union over whether to give vouchers to pharma to develop badly needed antibiotics. Read More STAT+: Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported By Ed Silverman and John Wilkerson Molly Ferguson for STAT The FDA and NIH have only carried out limited enforcement activities for failure to comply with ClinicalTrials.gov requirements. Read More STAT+: For only the second time, a big drugmaker offers a warranty on a medicine By Ed Silverman Kristoffer Tripplaar/Sipa via AP Images Sanofi is offering a warranty that will cover the cost for any hospital if its drug, Cablivi, fails to work in treating aTTP. Read More Sponsored Insight by Genentech STAT E-Book — Science and Society: How medicine's revolutionary advances are changing the way we live The 2022 STAT Summit brought together some of the world's top biotech researchers, public health experts, and industry executives to discuss both the transformative power of new technologies and the formidable challenges of this complex and fast-changing era. Download our latest e-book to learn more. Listen: How blockbusters get made, new vaccines for RSV, and mRNA's Q score By Damian Garde and Meg Tirrell and Adam Feuerstein Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica. Read More STAT+: 'A cascade of failures': FDA cites Indian drugmaker for numerous quality control problems By Ed Silverman Sarah Silbiger/Getty Images The FDA accused a drugmaker of a “cascade of failures” for a litany of quality-control problems at a manufacturing plant. Read More Thursday, January 19, 2023       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser